| Eswatini | | |
Prevalence of anaemia in women of reproductive age (15?49 years) (%) | 30.7% (2019) [68/192countries] | | | Age-standardized prevalence of hypertension among adults aged 30-79 years (%) | 42.5% (2019) [51/192countries] | | |
|
| Eswatini | | |
New HIV infections (per 1000 uninfected population) | 5.28 (2020) [1/130countries] | | | Tuberculosis incidence (per 100,000 population) | 348.0 (2021) [18/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.8 (2020) [53/194countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 35.2 (2019) [10/183countries] | | |
|
| Eswatini | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 127.9 (2020) [131/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 1.4 (2020) [158/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 0.6 (2020) [168/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 22.8 (2020) [170/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 84.5 (2020) [1/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 2.6 (2020) [175/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 1.1 (2020) [180/183countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 0.8 (2020) [165/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.2 (2020) [184/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 1.1 (2020) [177/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.0 (2020) [166/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 4.0 (2020) [134/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 3.6 (2020) [150/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 4.9 (2020) [81/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.2 (2020) [171/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.1 (2020) [161/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 3.3 (2020) [156/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 2.2 (2020) [102/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [120/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 3.4 (2020) [163/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 0.7 (2020) [180/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 41.6 (2020) [90/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 1.6 (2020) [181/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.2 (2020) [155/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 0.8 (2020) [166/184countries] | | |
|
| Eswatini | | |
Suicide, age-standardized (per 100 000 population) | 40.46 (2019) [3/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 78.67 (2019) [2/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 6.41 (2019) [37/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 19.19 (2019) [10/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 33.07 (2019) [9/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 4.60 (2019) [49/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 39.92 (2019) [7/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 78.83 (2019) [5/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.94 (2019) [64/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 75.03 (2019) [2/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 160.70 (2019) [2/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 8.76 (2019) [23/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 92.98 (2019) [2/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 168.00 (2019) [2/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 10.67 (2019) [28/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 68.39 (2019) [2/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 119.60 (2019) [2/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 12.33 (2019) [45/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 51.68 (2019) [11/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 104.30 (2019) [5/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 15.58 (2019) [46/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 52.31 (2019) [34/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 124.30 (2019) [11/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 22.51 (2019) [45/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 105.80 (2019) [42/183countries] | | |
|
|